Abstract
Factors that impact the need for and the effectiveness of blood transfusions depend on the recipient’s physiologic tolerance to acute anemia and the quality of the donor units that they receive. To date, indirect methods are used to determine the needs for blood transfusions and their efficacy in both clinical research and patient care settings. Methods that provide clear information on oxygen levels in tissues would fill both critical gaps in the global understanding of blood transfusion. However, only a limited number of techniques are truly useful to achieve the goals of assessing the direct measurement of tissue oxygen partial pressures (pO2). This is because most methods do not directly measure tissue oxygen but instead are based on surrogates presumed to adequately define oxygenation of critical organs. This does not mean that indirect substitutes for tissue pO2 have been valueless. Nonetheless, direct measurements are needed to understand oxygenation at the tissue level. This synopsis describes the potential role of electron paramagnetic resonance (EPR) oximetry to provide guidance in transfusion medicine, pointing out the current benefits and limitations of using this technique. Further, we suggest approaches toward evolving this technique to optimize measurements of oxygenation in proof-of-concept and clinical transfusion assessment settings.
Similar content being viewed by others
Notes
A predicate product is a medical product that may be legally marketed in the U.S. and used as a point of comparison for new medical products seeking FDA approval.
References
R. Sender, S. Fuchs, R. Milo, Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14(8), e1002533 (2016)
J.G. Vostal, P.W. Buehler, M.P. Gelderman et al., Proceedings of the food and drug administration’s public workshop on new red blood cell product regulatory science 2016. Transfusion 58(1), 255–266 (2018)
M.I. Ochocinskaa, S.L. Spitalnik, A. Abuhamad et al., NIH Workshop 2018: towards minimally invasive or noninvasive approaches to assess tissue oxygenation pre- and post-transfusion. Transfus. Med. Rev. 20(6), S0887-7963 (2020)
L.J. Dumont, J.P. AuBuchon, Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 48(6), 1053–1060 (2008)
R.O. Francis, S. Mahajan, F. Rapido et al., Re-examination of chromium-51 labeled posttransfusion red blood cell recovery method. Transfusion 59(7), 2264–2275 (2019)
C. Roussel, P.A. Buffet, P. Amireault, Measuring post-transfusion recovery and survival of red blood cells: strengths and weaknesses of chromium-51 labeling and alternative methods. Front. Med. 15(5), 1–8 (2018)
J.L. Carson, S.J. Stanworth, N. Roubinian et al., Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst. Rev. 16(10), 1–115 (2016)
J.L. Carson, S.J. Stanworth, J.H. Alexander et al., Clinical trials evaluating red blood cell transfusion thresholds: an updated systematic review and with additional focus on patients with cardiovascular disease. Am. Heart J. 200, 96–101 (2018)
K.M. Trentino, S.L. Farmer, M.F. Leahy et al., Systematic reviews and meta-analyses comparing mortality in restrictive and liberal haemoglobin thresholds for red cell transfusion: an overview of systematic reviews. BMC Med. 18(1), 154 (2020)
J.D. Roback, Perspectives on the impact of storage duration on blood quality and transfusion outcomes. Vox Sang. 111(4), 357–364 (2016)
T. Yoshida, M. Prudent, A. D’Alessandro, Red blood cell storage lesion: causes and potential consequences. Blood Transfus. 17(1), 27–52 (2019)
H. Hou, J.H. Baek, H. Zhang et al., Electron paramagnetic resonance oximetry as a novel approach to measure the effectiveness and quality of red blood cell transfusions. Blood Transfus. 17(4), 296–306 (2019)
G.H.W. Lim, M. Wortis, R. Mukhopadhyay, Stomatocyte-discocyte-echinocyte sequence of the human red blood cell: evidence for the bilayer- couple hypothesis from membrane mechanics. Proc. Natl. Acad. Sci. 99(26), 16766–16769 (2002)
R.M. Caston, W. Schreiber, H. Hou et al., Development of the implantable resonator system for clinical EPR oximetry. Cell Biochem. Biophys. 75(3–4), 275–283 (2017)
N. Khan, H. Hou, H.M. Swartz et al., Direct and repeated measurement of heart and brain oxygenation using in vivo EPR oximetry. Methods Enzymol. 564, 529–552 (2015)
J. Jiang, T. Nakashima, K.J. Liu et al., Measurement of PO2 in liver using EPR oximetry. J. Appl. Physiol. 80(2), 552–558 (1985)
H. Hou, N. Khan, S. Gohain et al., Pre-clinical evaluation of OxyChip for long-term EPR oximetry. Biomed. Microdevices 20(2), 1–10 (2018)
D. Tse, P. Kuppusamy, Biocompatibility of oxygen-sensing paramagnetic implants. Cell Biochem. Biophys. 77(3), 197–202 (2019)
G. Meenakshisundaram, E. Eteshola, R.P. Pandian et al., Oxygen sensitivity and biocompatibility of an implantable paramagnetic probe for repeated measurements of tissue oxygenation. Biomed. Microdevices 11(4), 817–826 (2009)
A.B. Flood, V.A. Wood, W. Schreiber, Guidance to transfer “bench-ready” medical technology into usual clinical practice: case study—sensors and spectrometer used in EPR oximetry. Adv. Exp. Med. Biol. 1072, 233–239 (2018)
P.E. Schaner, J.R. Pettus, A.B. Flood et al., OxyChip implantation and subsequent electron paramagnetic resonance oximetry in human tumors is safe and feasible: first experience in 24 patients. Front. Oncol. 27(10), 572060 (2020)
A.B. Flood, V.A. Wood, H.M. Swartz, Using India ink as a sensor for oximetry: evidence of its safety as a medical device. Adv. Exp. Med. Biol. 977, 297–312 (2017)
N. Charlier, N. Beghein, B. Gallez, Development and evaluation of biocompatible inks for the local measurement of oxygen using in vivo EPR. NMR Biomed. 17(5), 303–310 (2004)
H. Hou, R. Dong, H. Li et al., Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators. J. Magn. Reson. 214(1), 22–28 (2012)
H. Hou, H. Li, R. Dong, S. Mupparaju et al., Cerebral oxygenation of the cortex and striatum following normobaric hyperoxia and mild hypoxia in rats by EPR oximetry using multi-probe implantable resonators. Adv. Exp. Med. Biol. 701, 61–67 (2011)
H. Hou, N. Khan, J. Lariviere, Skeletal muscle and glioma oxygenation by carbogen inhalation in rats: a longitudinal study by EPR oximetry using single-probe implantable oxygen sensors. Adv. Exp. Med. Biol.. 812, 97–103 (2014)
H. Li, H. Hou, A. Sucheta et al., Implantable resonators–a technique for repeated measurement of oxygen at multiple deep sites with in vivo EPR. Adv. Exp. Med. Biol. 662, 265–272 (2010)
Acknowledgements
The concepts presented herein are the result of extensive discussion, scientific knowledge exchange, and friendship between Drs. Harold M Swartz, Ann Barry Flood and Paul W Buehler. Dr. Buehler expresses his gratitude for the opportunity to have developed a greater understanding of EPR oximetry and its applications because of this scientific friendship and wishes Dr. Swartz many more years of scientific pursuit, success, and happiness!
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
ABF and HMS are co-owners of Clin-EPR, LLC which manufactures EPR instruments for investigational use. PWB has no disclosures or conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Buehler, P.W., Flood, A.B. & Swartz, H.M. Expanding EPR Oximetry into Transfusion Medicine. Appl Magn Reson 52, 1509–1519 (2021). https://doi.org/10.1007/s00723-021-01394-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00723-021-01394-3